Top Story

Michael H. Davidson, MD, discusses PCSK9 as a target of therapy

October 24, 2014

BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, outlines a session he participated in at the Cardiometabolic Health Congress on PCSK9 as a target for cholesterol-lowering therapy.

Davidson, clinical professor of medicine and director of the lipid clinic at the University of Chicago Pritzker School of Medicine, noted that in less than a decade since discovering that PCSK9 deficiencies led to reduced LDL cholesterol and CV risk, multiple clinical trials have indicated the effectiveness of PCSK9 as an LDL-lowering therapy. He also addressed the lowering of LDL as a target of therapy, and acknowledged that several outcome trials assessing this possibility are currently underway.

figure Meeting News CoverageVideo

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed primarily at diabetes or metabolic disease poses…
figure Meeting News Coverage

Efficacy, safety of aspirin for treatment of patients with diabetes, CAD unclear

October 24, 2014
BOSTON — The benefits of using aspirin, alone or with a platelet inhibitor, for the treatment of patients with diabetes at high-risk for CVD are still unclear…
figure Meeting News Coverage

Expert examines contribution of aldosterone in obesity-related hypertension

October 24, 2014
BOSTON — At the Cardiometabolic Health Congress, Colleen M. Majewski, MD, discussed the link between elevated aldosterone and obesity-related hypertension, and…
More News Headlines »
CME
figure

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
Meeting News Coverage Video
figure

Michael H. Davidson, MD, discusses PCSK9 as a target of therapy

October 24, 2014
BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, outlines a session he…
More »
CME
figure

Acromegaly: Pathophysiology, Signs, Symptoms, and Complications - Part 1 of 5

This activity is supported by an educational grant from Genentech.

An understanding of the pathophysiological mechanisms of acromegaly is important to its various complications as well…
More »